Alaska Department of Revenue Boosts Position in Integer Holdings Co.

Trending News ☀️

This boost comes as the company’s share price has been struggling in recent months. However, the department believes that Integer Holdings($NYSE:ITGR) is a good long-term investment and is committed to holding onto its shares. While the company’s short-term prospects may be uncertain, the department is confident that Integer Holdings will be able to rebound and generate strong returns in the future.

Earnings

In the latest earning report of FY2022 Q3, INTEGER HOLDINGS earned 1279.6M USD in total revenue, earned 78.1M USD in net income. Compared to previous year, 4.8% increase in total revenue, 19.3% decrease in net income. INTEGER HOLDINGS’s total revenue reached from 1073.4M USD to 1279.6M USD in the last 3 years.

Compared to the previous year, there was a 4.8% increase in total revenue and a 19.3% decrease in net income. INTEGER HOLDINGS’ total revenue reached from 1073.4M USD to 1279.6M USD in the last 3 years.

Share Price

So far, media sentiment towards INTEGER HOLDINGS has been mostly positive. On Tuesday, INTEGER HOLDINGS stock opened at $61.9 and closed at $61.2, up by 0.1% from its last closing price of 61.2.

VI Analysis

Integer Holdings Corporation, through its subsidiaries, provides medical device outsourcing solutions in the United States and internationally. It operates in two segments, Medical Device Outsourcing Solutions and Contract Manufacturing. The company’s products include cardiology, neurovascular, orthopedics, vascular, urology, and general surgical devices. The company’s fundamentals reflect its long term potential.

Based on the VI Star Chart, Integer Holdings has an intermediate health score of 6/10 with regard to its cashflows and debt, and is likely to safely ride out any crisis without the risk of bankruptcy. Integer Holdings is classified as a ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. Due to its moderate growth rate, such company is deemed less risky and volatile as it pursuits a sustainable growth rate.

Summary

A number of other institutional investors have also recently bought and sold shares of the stock. ITGR has been the subject of a number of recent research reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the company’s stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

The disclosure for this sale can be found here. Integer Holdings Corporation is a medical device outsource manufacturer serving Original Equipment Manufacturers in the cardiac rhythm management , cardiovascular and neuromodulation markets worldwide with innovative design, development and manufacturing services.